Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles Parkes

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Briefings in Functional Genomics|March 26, 2011
Genome-wide association studies and Crohn's diseaseJames C Lee, Miles Parkes
Gut|March 4, 2019
Diverticular disease: picking pockets and population biobanksRinse K Weersma, Miles Parkes
Autophagy|October 9, 2007
Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's diseaseDunecan C O Massey, Miles Parkes
Nature Reviews. Gastroenterology & Hepatology|July 27, 2021
Moving towards more patient-centred clinical trials in IBDNurulamin M Noor, Miles Parkes, Tim Raine
Gastroenterology|January 7, 2022
How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?Bram Verstockt, Miles Parkes, James C Lee
The Lancet. Gastroenterology & Hepatology|May 10, 2025
U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitisNurulamin M Noor, Miles Parkes, Tim Raine
Inflammatory Bowel Diseases|July 16, 2024
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian
Inflammatory Bowel Diseases|October 24, 2024
Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?"Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian
Journal of Crohn'S & Colitis|April 2, 2011
The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomesLisa Sharkey, Fran Bredin, Allison Nightingale, et al.
BMJ Case Reports|January 19, 2026
STAT3 gain-of-function mutation presenting with adult-onset recurrent abdominal pain, fever and lymphadenopathy, managed by JAK inhibitor therapyRofaida Desoki, Stephany Barreda, Samir Khwaja, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Briefings in Functional Genomics|March 26, 2011
Genome-wide association studies and Crohn's diseaseJames C Lee, Miles Parkes
Gut|March 4, 2019
Diverticular disease: picking pockets and population biobanksRinse K Weersma, Miles Parkes
Autophagy|October 9, 2007
Genome-wide association scanning highlights two autophagy genes, ATG16L1 and IRGM, as being significantly associated with Crohn's diseaseDunecan C O Massey, Miles Parkes
Nature Reviews. Gastroenterology & Hepatology|July 27, 2021
Moving towards more patient-centred clinical trials in IBDNurulamin M Noor, Miles Parkes, Tim Raine
Gastroenterology|January 7, 2022
How Do We Predict a Patient's Disease Course and Whether They Will Respond to Specific Treatments?Bram Verstockt, Miles Parkes, James C Lee
The Lancet. Gastroenterology & Hepatology|May 10, 2025
U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitisNurulamin M Noor, Miles Parkes, Tim Raine
Inflammatory Bowel Diseases|July 16, 2024
Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian
Inflammatory Bowel Diseases|October 24, 2024
Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?"Mohmmed Tauseef Sharip, Miles Parkes, Sreedhar Subramanian
Journal of Crohn'S & Colitis|April 2, 2011
The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: long term outcomesLisa Sharkey, Fran Bredin, Allison Nightingale, et al.
BMJ Case Reports|January 19, 2026
STAT3 gain-of-function mutation presenting with adult-onset recurrent abdominal pain, fever and lymphadenopathy, managed by JAK inhibitor therapyRofaida Desoki, Stephany Barreda, Samir Khwaja, et al.
Pageof 16